From: Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway
Variable | N | Univariable | Multivariable | ||||
---|---|---|---|---|---|---|---|
HR | 95Â % CI | P | HR | 95Â % CI | P | ||
Age | |||||||
 ≤55 | 34 | 1 |  |  |  |  |  |
 >55 | 26 | 0.615 | 0.234–1.617 | 0.324 |  |  |  |
Sex | |||||||
 Male | 37 | 1 |  |  | 1 |  |  |
 Female | 23 | 0.317 | 0.128–0.784 | 0.013 | 0.790 | 0.649–2.175 | 0.649 |
Differentiation | |||||||
 Well | 24 | 1 |  |  | 1 |  |  |
 Moderate/poor | 36 | 3.829 | 1.537–9.538 | 0.004 | 2.323 | 0.760–7.103 | 0.139 |
T stage | |||||||
 T1 + T2 | 33 | 1 |  |  | 1 |  |  |
 T3 + T4 | 27 | 3.638 | 1.638–8.082 | 0.002 | 1.087 | 0.397–2.972 | 0.871 |
N status | |||||||
 N− | 35 | 1 |  |  | 1 |  |  |
 N+ | 25 | 7.706 | 3.206–18.522 | 0.000 | 1.501 | 0.4594–4.908 | 0.501 |
Clinical stage | |||||||
 I + II | 23 | 1 |  |  | 1 |  |  |
 III + IV | 37 | 8.873 | 3.902–13.623 | 0.001 | 13.806 | 1.333–143.024 | 0.028 |
HMAG2 staining | |||||||
 Negative | 23 | 1 |  |  | 1 |  |  |
 Positive | 37 | 14.779 | 3.431–63.665 | 0.000 | 5.785 | 1.066–31.391 | 0.042 |
Snail staining | |||||||
 Negative | 35 | 1 |  |  | 1 |  |  |
 Positive | 25 | 3.819 | 1.738–8.393 | 0.001 | 0.976 | 0.280–3.402 | 0.970 |